» Articles » PMID: 38184577

Association Between the Cumulative Average Triglyceride Glucose-body Mass Index and Cardiovascular Disease Incidence Among the Middle-aged and Older Population: a Prospective Nationwide Cohort Study in China

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Findings from earlier research have established that insulin resistance (IR) is implicated in atherosclerosis progression, representing a noteworthy risk factor for cardiovascular disease (CVD). Recently, the triglyceride glucose-body mass index (TyG-BMI) has been introduced as a straightforward and robust alternative indicator for early detection of IR. Nevertheless, there is a scarcity of studies that have examined the capability of TyG-BMI for predicting incident CVD. Consequently, the core objective of this study was to determine whether the cumulative average TyG-BMI correlated with CVD incidence.

Methods: All data was sourced from the China Health and Retirement Longitudinal Study (CHARLS). The exposure was the cumulative average TyG-BMI, determined by the average of TyG-BMI values for the baseline and follow-up investigations (Wave 1 in 2011, Wave 3 in 2015, respectively). The calculation of TyG-BMI involved a combination of triglyceride, fasting blood glucose, and body mass index. The primary outcome was incident CVD. Logistic regression analyses as well as restricted cubic spline (RCS) regression analyses were performed for examining the association between the cumulative average TyG-BMI and CVD incidence.

Results: In all, 5,418 participants were enrolled in our analysis, with 2,904 (53.6%) being female, and a mean (standard deviation, SD) age of 59.6 (8.8) years. The mean (SD) cumulative average TyG-BMI among all participants was 204.9 (35.7). Totally, during a 4-year follow-up, 543 (10.0%) participants developed CVD. The fully adjusted logistic regression analysis revealed a significant association between the cumulative average TyG-BMI and incident CVD [odds ratio (OR), 95% confidence interval (CI): 1.168, 1.040-1.310, per 1 SD increase]. The RCS regression analysis displayed a positive, linear association of the cumulative average TyG-BMI with CVD incidence (P for overall = 0.038, P for nonlinear = 0.436).

Conclusions: Our study revealed a noteworthy correlation between the cumulative average TyG-BMI and incident CVD among the middle-aged and older population. The cumulative average TyG-BMI emerges as a valuable tool that may enhance the primary prevention and treatment of CVD.

Citing Articles

Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study.

Mo D, Zhang P, Zhang M, Dai H, Guan J Cardiovasc Diabetol. 2025; 24(1):116.

PMID: 40065297 PMC: 11895360. DOI: 10.1186/s12933-025-02675-y.


Association between inflammatory score, healthy lifestyle, and cardiovascular disease: a national cohort study.

Zhao H, Lv J, Gao Y, Hu B, Du Z, Wang Y Front Nutr. 2025; 12:1534458.

PMID: 40051968 PMC: 11882400. DOI: 10.3389/fnut.2025.1534458.


Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.

Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X Cardiovasc Diabetol. 2025; 24(1):98.

PMID: 40022122 PMC: 11871812. DOI: 10.1186/s12933-025-02662-3.


Sarcopenia and Cardiovascular Diseases in Individuals With Diabetes or Prediabetes.

Wang X, Zeng Q, Yu X, Li S J Clin Hypertens (Greenwich). 2025; 27(3):e70024.

PMID: 40021136 PMC: 11870746. DOI: 10.1111/jch.70024.


Association between triglyceride-glucose index and its composite obesity indexes and cardio-renal disease: analysis of the NHANES 2013-2018 cycle.

Wu Y, Liu C, Cao J Front Endocrinol (Lausanne). 2025; 16:1505808.

PMID: 39959622 PMC: 11825323. DOI: 10.3389/fendo.2025.1505808.


References
1.
Moshkovits Y, Rott D, Chetrit A, Dankner R . The association between insulin sensitivity indices, ECG findings and mortality: a 40-year cohort study. Cardiovasc Diabetol. 2021; 20(1):97. PMC: 8103608. DOI: 10.1186/s12933-021-01284-9. View

2.
Song B, Zhao X, Yao T, Lu W, Zhang H, Liu T . Triglyceride Glucose-Body Mass Index and Risk of Incident Type 2 Diabetes Mellitus in Japanese People With Normal Glycemic Level: A Population-Based Longitudinal Cohort Study. Front Endocrinol (Lausanne). 2022; 13:907973. PMC: 9336540. DOI: 10.3389/fendo.2022.907973. View

3.
Huang Y, Huang J, Lin C, Chien H, Lin Y, Wang C . Comparison of Innovative and Traditional Cardiometabolic Indices in Estimating Atherosclerotic Cardiovascular Disease Risk in Adults. Diagnostics (Basel). 2021; 11(4). PMC: 8067018. DOI: 10.3390/diagnostics11040603. View

4.
Hu H, Han Y, Cao C, He Y . The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population. J Transl Med. 2022; 20(1):398. PMC: 9446832. DOI: 10.1186/s12967-022-03611-4. View

5.
Di Pino A, DeFronzo R . Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocr Rev. 2019; 40(6):1447-1467. PMC: 7445419. DOI: 10.1210/er.2018-00141. View